Senior Hire and Move at US Healthcare Specialist

US provider Healthcare Research & Analytics (HRA) has appointed Oleh Denysyk as President, replacing John Maglione who is moving to an undisclosed 'new role' in the company.

HRA offers qual and quant, custom and syndicated market research services for the pharmaceutical, biotech and medical device markets. Denysyk (pictured) previously ran his own agency Pharmaceutical Intelligence, prior to which he was Director of Market Analytics and Business Strategy at Genentech/Roche; Director at Pfizer; and Director of Strategic Assessment and New Product Marketing at Novartis.

In his new role, he will lead all HRA operations, including overseeing client research projects and developing initiatives to grow the company.

Tighe Blazier, COO of MJH & Associates, which owns and operates HRA, comments: 'We are very fortunate to welcome Oleh as President of HRA, as he brings a distinguished career and leadership in our industry. We acknowledge John for his service to HRA over the last two years and look forward to his continued contribution to our company.'

Maglione joined the company in 2011 from his previous role as Executive Director, HIV Sales and Patient Community Affairs at Bristol-Myers Squibb, where he worked for 23 years.

Web site: www.hraresearch.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.